US Broker Ratings

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A High-Stakes Bet in Biotechnology with 135% Upside Potential

Apogee Therapeutics, Inc. (NASDAQ: APGE), a clinical-stage biotechnology firm, has captured investor attention with its promising pipeline of biologics aimed at treating a range of inflammatory..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring a 40% Upside Potential

Schrödinger, Inc. (NASDAQ: SDGR), standing at the intersection of technology and healthcare, presents a compelling opportunity for investors who are keen on groundbreaking innovation in drug..

Amicus Therapeutics (FOLD) Stock Analysis: Exploring a 100% Upside Potential

Investors eyeing the biotechnology sector may find Amicus Therapeutics, Inc. (NASDAQ: FOLD) a compelling consideration, particularly given the significant upside potential reflected in recent analyst ratings...

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating a 9.95% Potential Upside Amidst Biotech Volatility

PTC Therapeutics, Inc. (NASDAQ: PTCT), a stalwart in the biotechnology sector, commands attention with its robust pipeline of treatments for rare disorders. As a healthcare company..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unpacking a 73% Potential Upside

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is capturing the spotlight in the biotechnology sector with a compelling narrative centered around its precision medicine oncology focus. Headquartered in..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Strong Buy Ratings Amid Robust Revenue Growth

Alignment Healthcare, Inc. (NASDAQ: ALHC) stands out in the Healthcare sector, particularly in the Healthcare Plans industry, with its consumer-focused platform dedicated to providing tailored healthcare..

Ultragenyx Pharmaceutical Inc. (RARE): Exploring a Potential 186% Upside Amidst Strong Buy Ratings

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a trailblazer in the biotech sector, is capturing investor attention with a remarkable potential upside of 186.21%. As a biopharmaceutical company,..

Premier, Inc. (PINC) Investor Outlook: Navigating Healthcare with a 3.02% Dividend Yield

Premier, Inc. (NASDAQ: PINC), a prominent player in the healthcare sector, operates at the intersection of health information services, providing innovative solutions through its dual segments:..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Unpacking a 22.44% Potential Upside in the Medical Instruments Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT) stands as a beacon of innovation in the medical instruments and supplies industry. Operating within the healthcare sector, this Massachusetts-based company..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Exploring a 37% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is drawing significant attention in the biotechnology sector as it continues to forge a promising path in developing innovative treatments for..

SS Innovations International (SSII) Stock Analysis: Exploring Revenue Growth and Strategic Positioning in the Booming Medical Devices Sector

SS Innovations International Inc. (SSII), a formidable player in the healthcare sector, specifically within the medical devices industry, is making waves from its base in Gurugram,..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Navigating the Future of Biotech with a $3.59 Billion Market Cap

Ascentage Pharma Group International (AAPG), a prominent Chinese biotechnology company, is making significant strides in the healthcare sector with its innovative therapies for cancer and chronic..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 37% Potential Upside Amidst Biotech Innovations

As a prominent player in the biotechnology sector, ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) has consistently demonstrated its commitment to advancing treatments for central nervous system (CNS)..

Addus HomeCare Corporation (ADUS): Investor Outlook with a Promising 20.48% Upside

Addus HomeCare Corporation (NASDAQ: ADUS) is catching the attention of investors in the healthcare sector with its robust growth prospects and significant potential upside. Serving the..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: A Deep Dive into Potential 32.55% Upside for Investors

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector specializing in medical instruments and supplies, presents a compelling investment narrative with potential upside,..

Haemonetics Corporation (HAE) Stock Analysis: Navigating a 63.42% Potential Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector might find Haemonetics Corporation (NYSE: HAE) an intriguing prospect, given its substantial potential upside. With a market capitalization of..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Unpacking the 40% Potential Upside in Biotech

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) has been capturing attention in the biotechnology sector, with an impressive 40.68% potential upside according to analyst consensus. This Canadian company,..

Belite Bio, Inc (BLTE) Investor Outlook: Exploring a 27.74% Potential Upside in Biotech

Belite Bio, Inc (NASDAQ: BLTE), a promising player in the biotechnology sector, is capturing the attention of investors with its innovative approach to tackling retinal degenerative..

Alvotech (ALVO) Stock Analysis: Unveiling a 108% Potential Upside in the Biosimilar Market

Alvotech (NASDAQ: ALVO), a prominent player in the healthcare sector focusing on biosimilar medicines, presents a compelling investment narrative with a remarkable potential upside of 108.33%...

Galapagos NV (GLPG) Stock Report: Navigating a Challenging Biotech Landscape with -25.33% Potential Downside

Galapagos NV (NASDAQ: GLPG), a prominent biotechnology firm based in Belgium, is making waves in the healthcare sector with its innovative focus on oncology and immunology...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds